Biocon Limited has informed the Exchange regarding a press release dated December 11, 2024, titled "Biocon Biologics Recognized as Asia IP Elite for 2024 by IAM, Cementing Leadership in Intellectual Property Excellence".
Press Release Dec 11 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Biocon
- Press Release Nov 27 2024
- Press Release Oct 30 2024
- Press Release Oct 28 2024
- Press Release Oct 25 2024
- Biocon Biologics Announces Results of Aflibercept Switching Study at American Academy of Ophthalmology Annual Meeting
Later from Biocon
- Press Release Jan 07 2025
- Press Release Jan 09 2025
- Biocon Limited Press Release Jan 27 2025
- Press Release Jan 30 2025
- Press Release Feb 06 2025
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon